| Home > Publications database > Silmitasertib (CX-4945), a Clinically Used CK2-Kinase Inhibitor with Additional Effects on GSK3β and DYRK1A Kinases: A Structural Perspective > Access to Fulltext |
grygier-et-al-2023-silmitasertib-(cx-4945)-a-clinically-used-ck2-kinase-inhibitor-with-additional-effects-on-gsk3β-and
|
|||||||
| version 1 |
| ||||||